HERTFORDSHIRE, England and PITTSBURGH, Feb. 22, 2019 — (Healthcare Sales & Marketing Network) — Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg and 12 mg/3 m… Biopharmaceuticals, Drug Delivery, Generics, Product Launch Mylan, Buprenorphine, Naloxone, Suboxone, Sublingual (Source: HSMN NewsFeed)
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
